Journal of Hematology

ISSN 1927-1212 print
ISSN 1927-1220 online
Frequency: Quarterly
Journal Access: Open Access
Journal scope: Journal of Hematology is an international, peer-reviewed journal, publishing original contributions describing basic research and clinical investigation of hematology and transfusion medicine, on the cellular, molecular, prevention, diagnosis, therapy and prognosis aspects.
Indexed and covered by: Chemical Abstract (CA); Directory of Open Access Journals (DOAJ);
Worldcat; Google; Google Scholar; JournalTOCs; PubMed: selected citations.
Journal archiving and digital preservation: Portico


Highlights

  • Associations Between Initial Presentation of Multiple Myeloma and Renal Function: the Experience of Two European Centers

    This study aimed to describe the baseline renal, histopathological and hematological characteristics and any clinical or biochemical associations of patients with a first coded diagnosis of multiple myeloma (MM).

    Read More >>
  • Treatment of Anemia Owing to Increased Menstrual Blood Loss: Activity of Physiological Modulators

    Heavy menstrual bleeding can lead to iron-deficiency anemia. The objective was to ascertain whether daily administration of a formula containing iron, essential amino acids, ascorbic acid and B-group vitamins for 28 days will increase hemoglobin levels by 0.5 g/dL and reduce menstrual bleeding.

    Read More >>
  • Concurrent Presentation of High-Grade Lymphoma and Metastatic Pancreatic Neuroendocrine Tumor 14 Years After Renal Transplant

    The development of malignancy, especially lymphoma, is common after solid organ transplant. However, concurrent malignancies are rare and result in a diagnostic and treatment dilemma, particularly in the post-transplant setting.

    Read More >>
  • Arterial and Venous Estimation of Hemoglobin: A Correlational Study

    The objective of this study was to identify the correlation between arterial blood gas (ABG) hemoglobin and venous hemoglobin in acutely ill patients.

    Read More >>
  • A Rare Variant of Aggressive T-Cell Large Granular Lymphocyte Leukemia Associated With Hepatic Fibrosis and Trisomy 8

    Aggressive T-cell large granular lymphocytic leukemia (T-LGL) is a rare entity with a poor prognosis, the main clinical findings being splenomegaly, lymphadenopathy, thrombocytopenia and a CD3+/CD56+ phenotype.

    Read More >>
  • Mobile Thrombus in the Ascending Aorta Associated With Acute Myocardial Infarction

    The presence of thrombus in the ascending aorta is uncommon but it has been implicated in systemic thromboembolism.

    Read More >>

Viewpoints

 

 

Featured Article

 

Potential Benefits of Metformin Use in Sickle Cell Anemia
Sickle cell anemia (SCA) is one of the most important genetic disorders known to mankind. Even with the impressive advances in medical science, effective treatment and cure remain challenging. Currently available treatments including hydroxyurea, which is the only FDA approved drug for SCA, and hemopoietic stem cell transplantation all have significant limitations, so the search for new therapeutic options continues. Read the Full Text

Beta-Globin Haplotypes and Alpha-Thalassemia 3.7 kb Deletion in Sickle Cell Disease Patients From the Occidental Brazilian Amazon
Sickle cell disease (SCD) includes a group of inherited red blood cell disorders. SCD patients vary widely from person to person. We describe βS and βC haplotypes and α-thalassemia 3.7 kb genotypes from SCD patients Fundacao Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, AM. Our survey included 139 HbSS and 11 HbSC patients. Molecular genotypes have been identified by PCR-RFLP and α-thalassemia 3.7 kb deletion by ASO-PCR. Male/female distribution was 42.3%/57.7%. Read the Full Text


Imageofissue

Ebstein-Barr Virus-Negative Clonal Plasma Cell Proliferations Associated With Systemic Involvement of Primary Cutaneous T-Cell Lymphoma
We describe a 66-year-old man with a long-standing history of squamous cell carcinoma of the head and neck region who developed nodular-sclerosing subtype of classical Hodgkin lymphoma and primary cutaneous CD8-positive, cytotoxic variant of mycosis fungoides over a 1-year period of time. Within a few months of his diagnosis of primary cutaneous T-cell lymphoma, he developed systemic involvement of T-cell lymphoma in an axillary lymph node, bone marrow and lung. Full Text

Current Issue

Past Issues


Vol. 5, No. 4, Dec 2016

Table of Contents

Original Article

The Clinical Course and Prognosis of Patients With Essential Thrombocythemia Treated With Hydroxyurea and Low-Dose Aspirin in an 11-Year Follow-Up Abstract HTML PDF
Mozaffar Aznab, Fareydoon Fathi, Seyed Majid Ahmadi 117-122
doi: https://doi.org/10.14740/jh305w
Beta-Globin Haplotypes and Alpha-Thalassemia 3.7 kb Deletion in Sickle Cell Disease Patients From the Occidental Brazilian Amazon Abstract HTML PDF
Janaina Santana Carneiro, Marilda de Souza Goncalves, Sergio Roberto Lopes Albuquerque, Nelson Abrahim Fraiji, Jose Pereira de Moura Neto 123-128
doi: https://doi.org/10.14740/jh310w

Case Report

Ebstein-Barr Virus-Negative Clonal Plasma Cell Proliferations Associated With Systemic Involvement of Primary Cutaneous T-Cell Lymphoma Abstract HTML PDF
Smita C. Patel, Brett Mahon 129-137
doi: https://doi.org/10.14740/jh300w
Acute Hepatic Crisis in Sickle Cell Anemia: Favorable Outcome After Exchange Transfusion Abstract HTML PDF
Hassan K. Khalifeh, Cynthia T. Chamoun, Abir H. Elhoujairy, Wael A. Alkoussa, Chantal I. Zeidan Lahoud, Gihan Al Masri 138-141
doi: https://doi.org/10.14740/jh304w
Severe Gestational Thrombocytopenia: A Case Report and Brief Review of the Literature Abstract HTML PDF
Mohamad Khaled Ramadan, Manal Hubeich, Saad Eddine Itani, Anas Mogharbil 142-150
doi: https://doi.org/10.14740/jh308w

Letter to the Editor

Could Anti-Erythropoietin Receptor Antibodies Be the Future Management of Beta Thalassemia Intermedia? Abstract HTML PDF
Ashraf Abdullah Saad 151-153
doi: https://doi.org/10.14740/jh285w
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Journal of Hematology, quarterly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.

IMPORTANT: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!